ProMIS Neurosciences, Inc. (PMN)
NASDAQ: PMN · Real-Time Price · USD
4.050
-0.110 (-2.64%)
At close: Nov 9, 2026, 4:00 PM EST
4.002
-0.048 (-1.18%)
After-hours: Nov 9, 2026, 7:57 PM EST
ProMIS Neurosciences Market Cap
ProMIS Neurosciences has a market cap or net worth of $36.32 million as of November 9, 2026. It is the 32,043rd most valuable company in the world and the 4,765th biggest in the United States. Its market cap has increased by 84.36% in one year.
Market Cap
36.32M
Enterprise Value
-17.14M
1-Year Change
84.36%
Global Rank
Country Rank
#4,765 United States
Category
ChartMarket Cap Chart
Since July 8, 2022, ProMIS Neurosciences's market cap has decreased from $66.60M to $36.32M, a decrease of -45.47%. That is a compound annual growth rate of -13.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 36.32M | 147.07% |
| Dec 31, 2025 | 14.70M | -52.58% |
| Dec 31, 2024 | 31.00M | 42.86% |
| Dec 29, 2023 | 21.70M | -41.67% |
| Dec 30, 2022 | 37.20M | -44.14% |
| Jul 8, 2022 | 66.60M | - |
View and export this data all the way back to 2022. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 39.69M |
| Grace Therapeutics | 38.92M |
| Hyperion DeFi | 38.69M |
| Aldeyra Therapeutics | 38.23M |
| Veru Inc. | 36.15M |
| Annovis Bio | 36.00M |
| Pelthos Therapeutics | 35.83M |
| Serina Therapeutics | 35.05M |